Antithrombogenic surface modifications in xenogenic pericardial vascular grafts: Initial in-vivo evaluation

2011 ◽  
Vol 59 (S 01) ◽  
Author(s):  
J Linneweber ◽  
F Voss ◽  
P Dohmen ◽  
W Erdbrügger ◽  
W Konertz
2008 ◽  
Vol 22 (S2) ◽  
pp. 605-605
Author(s):  
Mauricio Antonio Contreras ◽  
Mathew Douglas Phaneuf ◽  
Shengqian Wu ◽  
Martin J. Bide ◽  
Frank W. LoGerfo

2014 ◽  
Vol 6 (2) ◽  
Author(s):  
Derya Aytemiz ◽  
Yu Suzuki ◽  
Tomoko Shindo ◽  
Toshiki Saotome ◽  
Ryou Tanaka ◽  
...  

2016 ◽  
Vol 63 (6) ◽  
pp. 1620-1630.e4 ◽  
Author(s):  
Jennifer M. Bastijanic ◽  
Roger E. Marchant ◽  
Faina Kligman ◽  
Matthew T. Allemang ◽  
Ryan O. Lakin ◽  
...  

2019 ◽  
Vol 14 (7) ◽  
pp. 627-637 ◽  
Author(s):  
Riddhima Agarwal ◽  
Kevin M Blum ◽  
Andrew Musgrave ◽  
Ekene A Onwuka ◽  
Tai Yi ◽  
...  

Aim: This study evaluates scaffold degradation and neotissue formation as a function of sealant polymer composition in tissue-engineered vascular grafts (TEVGs). Materials & methods: Scaffolds fabricated from polyglycolic acid core and sealant composed of polycaprolactone (PCL), poly-L-lactic-acid (PLLA) or 50:50 copolymer poly(ε-caprolactone-co-L-lactide) (PCLA) were analyzed in vitro using accelerated degradation and scanning electron microscopy, and in vivo following implantation in a murine inferior vena cava interposition model. Results: In vitro and in vivo characterization revealed statistically greater degradation of PCLA compared with both PCL and PLLA scaffolds, with similar neotissue formation across all groups. The wall thickness of PLLA TEVGs was statistically greater than PCL TEVGs at 2 weeks postimplant. Conclusion: Results of this study can be used to inform the rational design of future TEVGs.


ASAIO Journal ◽  
2010 ◽  
Vol 56 (1) ◽  
pp. 61-66 ◽  
Author(s):  
Hiroyuki Kadono ◽  
Tsutomu Furuzono ◽  
Miwa Masuda ◽  
Masahiro Okada ◽  
Mitsuki Ueki ◽  
...  

2005 ◽  
Vol 25 (1_suppl) ◽  
pp. S598-S598 ◽  
Author(s):  
Laurent Martarello ◽  
Vincent J Cunningham ◽  
Julian C Matthews ◽  
Eugenii Rabiner ◽  
Steen Jakobsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document